Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naive pediatric patients with Crohn's disease in clinical practice

被引：0
|
作者：
Steiner, S. [1 ]
King, E. [2 ]
Park, K. [3 ]
Pashankar, D. [4 ]
Shashidhar, H. [5 ]
Sudel, B. [6 ]
Eichner, S. [7 ]
Chen, S. [2 ]
Pratt, J. [2 ]
Colletti, R. [8 ]
机构：
[1] Indiana Univ Sch Med, Riley Hosp Children, Indianapolis, IN 46202 USA
[2] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[3] Stanford Univ, Lucile Salter Packard Childrens Hosp, Palo Alto, CA 94304 USA
[4] Yale New Haven Childrens Hosp, New Haven, CT USA
[5] New Hampshires Hosp Children, Manchester, Lancs, England
[6] Univ Minnesota, Masonic Childrens Hosp, Minneapolis, MN USA
[7] AbbVie, N Chicago, IL USA
[8] Univ Vermont, Childens Hosp, Burlington, VT 05405 USA
[9] ImproveCareNow, Burlington, VT USA
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
10.1093/ecco-jcc/jjx002.024
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OP025
引用
下载
收藏
页码：S15 / S16
页数：2
相关论文
共 50 条
  • [31] Use of Vitamin D With Anti-Tumor Necrosis Factor Therapy for Crohn's Disease
    Bafutto, Mauro
    Oliveira, Enio Chaves
    Rezende Filho, Joffre
    GASTROENTEROLOGY RESEARCH, 2020, 13 (03) : 101 - 106
  • [32] Effectiveness of anti-Tumor Necrosis Factor agents in Pediatric Population with Uveitis
    Hajj-ali, Rula
    Choudhary, Maria
    Zeft, Andrew
    Spalding, Steven
    Srivastava, Sunil
    Lowder, Careen
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [33] Therapeutic Drug Monitoring Increases Drug Retention of Anti-Tumor Necrosis Factor Alpha Agents in Pediatric Patients With Crohn's Disease
    Gofin, Yoel
    Matar, Manar
    Shamir, Raanan
    Assa, Amit
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (08) : 1276 - 1282
  • [34] Increased Effectiveness of Early Therapy With Anti-Tumor Necrosis Factor-α vs an Immunomodulator in Children With Crohn's Disease
    Walters, Thomas D.
    Kim, Mi-Ok
    Denson, Lee A.
    Griffiths, Anne M.
    Dubinsky, Marla
    Markowitz, James
    Baldassano, Robert
    Crandall, Wallace
    Rosh, Joel
    Pfefferkorn, Marian
    Otley, Anthony
    Heyman, Melvin B.
    LeLeiko, Neal
    Baker, Susan
    Guthery, Stephen L.
    Evans, Jonathan
    Ziring, David
    Kellermayer, Richard
    Stephens, Michael
    Mack, David
    Oliva-Hemker, Maria
    Patel, Ashish S.
    Kirschner, Barbara
    Moulton, Dedrick
    Cohen, Stanley
    Kim, Sandra
    Liu, Chunyan
    Essers, Jonah
    Kugathasan, Subra
    Hyams, Jeffrey S.
    GASTROENTEROLOGY, 2014, 146 (02) : 383 - 391
  • [35] The Long-Term Effect of Early Anti-Tumor Necrosis Factor on Restoration of Growth in Pediatric Crohn's Disease
    Shim, Jung Ok
    Jeen, Yoon Tae
    GUT AND LIVER, 2018, 12 (03) : 221 - 222
  • [36] CDP571, a humanized anti-tumor necrosis factor-α monoclonal antibody in pediatric Crohn's disease
    Mamula, P
    Cohen, SA
    Ferry, GD
    Kirschner, BS
    Winter, HS
    Innes, A
    Patel, J
    Baldassano, RN
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (06) : 723 - 730
  • [37] Effectiveness of Adalimumab in Perianal Fistulas in Crohn's Disease Patients Naive to Anti-TNF Therapy
    Castano-Milla, Carlos
    Chaparro, Maria
    Saro, Cristina
    Barreiro-de Acosta, Manuel
    Garcia-Albert, Ana M.
    Bujanda, Luis
    Martin-Arranz, Maria D.
    Carpio, Daniel
    Munoz, Fernando
    Mancenido, Noemi
    Garcia-Planella, Esther
    Piqueras, Marta
    Calvet, Xavier
    Cabriada, Jose L.
    Botella, Belen
    Bermejo, Fernando
    Gisbert, Javier P.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (01) : 34 - 40
  • [38] Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn's disease
    Kane, Sunanda V.
    Jaganathan, Srihari
    Bedenbaugh, Angela V.
    Palmer, Liisa
    Schwartz, David A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (09) : 1821 - 1826
  • [39] Efficacy of restarting anti-tumor necrosis factor alpha agents after surgery in patients with Crohn's disease
    Hiraoka, Sakiko
    Takashima, Shiho
    Kondo, Yoshitaka
    Inokuchi, Toshihiro
    Sugihara, Yuusaku
    Takahara, Masahiro
    Kawano, Seiji
    Harada, Keita
    Kato, Jun
    Okada, Hiroyuki
    INTESTINAL RESEARCH, 2018, 16 (01) : 75 - 82
  • [40] Rates of tuberculosis infection in Crohn's Disease patients before and during anti-tumor necrosis factor therapy
    Georgieva, A. C.
    Atanassova, A.
    Mirchev, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I410 - I411
12345